Optimizing the Management of Patients with Advanced Non-Melanoma Skin Cancers in Community-based Dermatology, Oncology, and Dermato-oncology Practices
Post-Test/Evaluation

Questions marked with a * are required
29%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
Are you a Physician? 
A 58-year-old female previously diagnosed with nodular BCC in the left upper medial eyelid is in your office for a Mohs procedure. She has previously undergone multiple Mohs surgeries. She asks what the best treatment option would be if she has a recurrence. What treatment option would you recommend were she to have a recurrence?
A 64-year-old male treated with immunotherapy experienced adverse events consistent with Grade 3 diarrhea and Grade 3 fatigue. What is the best management option for these toxicities? 
What percentage of patients with locally advanced BCC and patients with metastatic BCC achieved a durable complete response in the ERIVANCE and STEVIE trials, respectively? 
An 89-year-old female with a history of type 2 diabetes, hypertension, coronary artery disease, and emphysema presents with a deeply invasive 4 cm BCC mass on her chin. She lives in an assisted living facility with no known living relatives. Would you consult with, or refer to, other healthcare professionals before making treatment recommendations/initiating treatment? 
Powered by QuestionPro